Ambu A/S (AMBBY)
19.00
0.00 (0.00%)
USD |
OTCM |
May 21, 16:00
Ambu Total Liabilities (Quarterly): 210.62M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 210.62M |
December 31, 2023 | 210.38M |
September 30, 2023 | 207.63M |
June 30, 2023 | 231.15M |
March 31, 2023 | 252.51M |
December 31, 2022 | 415.09M |
September 30, 2022 | 390.44M |
June 30, 2022 | 370.51M |
March 31, 2022 | 359.40M |
December 31, 2021 | 362.47M |
September 30, 2021 | 278.95M |
June 30, 2021 | 266.13M |
March 31, 2021 | 229.65M |
December 31, 2020 | 437.84M |
September 30, 2020 | 402.70M |
June 30, 2020 | 372.01M |
March 31, 2020 | 367.44M |
December 31, 2019 | 382.75M |
September 30, 2019 | 348.18M |
June 30, 2019 | 324.65M |
March 31, 2019 | 352.11M |
December 31, 2018 | 365.82M |
September 30, 2018 | 365.95M |
June 30, 2018 | 366.86M |
March 31, 2018 | 390.98M |
Date | Value |
---|---|
December 31, 2017 | 356.62M |
September 30, 2017 | 193.26M |
June 30, 2017 | 206.75M |
March 31, 2017 | 201.40M |
December 31, 2016 | 217.44M |
September 30, 2016 | 206.79M |
June 30, 2016 | 191.09M |
March 31, 2016 | 219.09M |
December 31, 2015 | 194.96M |
September 30, 2015 | 183.72M |
June 30, 2015 | 196.93M |
March 31, 2015 | 201.94M |
December 31, 2014 | 209.15M |
September 30, 2014 | 203.36M |
June 30, 2014 | 232.90M |
March 31, 2014 | 232.37M |
December 31, 2013 | 232.10M |
September 30, 2013 | 217.30M |
June 30, 2013 | 223.93M |
March 31, 2013 | 229.33M |
December 31, 2012 | 56.88M |
September 30, 2012 | 49.17M |
June 30, 2012 | 61.09M |
March 31, 2012 | 60.79M |
December 31, 2011 | 61.03M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
207.63M
Minimum
Sep 2023
437.84M
Maximum
Dec 2020
321.02M
Average
353.79M
Median
Total Liabilities (Quarterly) Benchmarks
Genmab A/S | 605.09M |
Ascendis Pharma A/S | 1.124B |
Galecto Inc | 4.318M |
Evaxion Biotech AS | 17.63M |
IO Biotech Inc | 12.69M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.021B |
Shareholders Equity (Quarterly) | 810.79M |
Current Ratio | 2.528 |
Net Debt Paydown Yield | 0.89% |